Free Trial

Truist Financial Cuts Ardent Health Partners (NYSE:ARDT) Price Target to $21.00

Ardent Health Partners logo with Medical background

Ardent Health Partners (NYSE:ARDT - Free Report) had its price objective reduced by Truist Financial from $22.00 to $21.00 in a research report report published on Monday,Benzinga reports. Truist Financial currently has a buy rating on the stock.

Several other research analysts have also recently commented on ARDT. Stephens reaffirmed an "overweight" rating and issued a $24.00 target price on shares of Ardent Health Partners in a research report on Thursday, September 19th. KeyCorp started coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They set an "overweight" rating and a $24.00 price objective for the company. Royal Bank of Canada reissued an "outperform" rating and issued a $23.00 target price on shares of Ardent Health Partners in a research note on Thursday, November 14th. Bank of America cut shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and cut their price target for the stock from $22.00 to $19.00 in a research note on Wednesday, November 6th. Finally, Leerink Partners upped their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the company an "outperform" rating in a research note on Tuesday, November 12th. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Ardent Health Partners has a consensus rating of "Buy" and an average target price of $22.00.

View Our Latest Analysis on Ardent Health Partners

Ardent Health Partners Price Performance

Shares of ARDT stock traded down $0.78 during mid-day trading on Monday, reaching $15.86. The stock had a trading volume of 280,838 shares, compared to its average volume of 299,809. Ardent Health Partners has a one year low of $14.57 and a one year high of $20.72. The company has a 50 day moving average of $16.71. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Institutional Trading of Ardent Health Partners

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. State Street Corp acquired a new position in Ardent Health Partners during the 3rd quarter worth about $1,977,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Ardent Health Partners during the third quarter valued at approximately $13,119,000. Goldentree Asset Management LP acquired a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $22,897,000. Jane Street Group LLC acquired a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $567,000. Finally, Franklin Resources Inc. bought a new position in Ardent Health Partners in the 3rd quarter worth approximately $15,839,000.

About Ardent Health Partners

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

See Also

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Should You Invest $1,000 in Ardent Health Partners Right Now?

Before you consider Ardent Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.

While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines